Bucladesine (GMP)
Product Specifications
UNSPSC Description
Bucladesine (Dibutyryl cAMP) (GMP) is a Bucladesine (HY-B0764B) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Bucladesine is a membrane permeable selective activator that activates cyclic adenosine phosphate dependent protein kinase A (PKA)[1].
Target Antigen
Phosphodiesterase (PDE); PKA
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease;Stem Cell/Wnt;TGF-beta/Smad
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bucladesine-gmp.html
Smiles
O=C(CCC)O[C@H]1[C@H](N2C(N=CN=C3NC(CCC)=O)=C3N=C2)O[C@@](CO4)([H])[C@@]1([H])OP4(O)=O
Molecular Weight
469.39
References & Citations
[1]Sharifzadeh M, et al. Post-training intrahippocampal infusion of nicotine–bucladesine combination causes a synergistic enhancement effect on spatial memory retention in rats[J]. European journal of pharmacology, 2007, 562(3): 212-220.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-B0764G/Bucladesine-GMP-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-B0764G/
Clinical Information
No Development Reported
CAS Number
362-74-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items